Search
Moclobemide
go.drugbank.com/drugs/DB01171ApprovedInvestigationalA reversible monoamine oxidase inhibitor (MAOI) selective for isoform A (RIMA) used to treat major depressive disorder. Most meta-analyses and most studies indicate that in the acute management of depression, moclobemide is more efficaci...
Products: Manerix Tab 100mg, MOCLOBEMID AL 300MGLisinopril
go.drugbank.com/drugs/DB00722ApprovedInvestigational[A184853] It functions by inhibition of angiotensin converting enzyme as well as the renin angiotensin aldosterone system.
Mixtures: LISIPLUS AL 10MG/12.5MG, LISILICH COMP 10MG/12.5MGProducts: LISINOPRIL AUROBINDO 30MG, Lisinopril 40mgDiltiazem
go.drugbank.com/drugs/DB00343ApprovedInvestigationalIt works through various mechanisms of action, but it primarily works by inhibiting the calcium influx into cardiac and vascular smooth muscle during depolarization. … Approved in 1982 by the FDA, it is a member of the non-dihydropyridine calcium channel blockers drug class.
Products: Nu-diltiaz Tab 30mg, AZEMTI 30MG TABLETRopinirole
go.drugbank.com/drugs/DB00268ApprovedInvestigationalIt is manufactured by GlaxoSmithKline Pharmaceuticals. Ropinirole was initially approved in 1997 by the FDA [FDA label] for the management of Parkinson's disease.
Products: ROPINIROL-HEXAL 3MG, ROPINIROL 1A PHARMA 3MGZidovudine
go.drugbank.com/drugs/DB00495ApprovedInvestigationalA dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group.
Mixtures: COMBIVIR 150MG/300MG, COMBIVIR 150MG/300MGProducts: ZIDO H ® SOLUCION ORAL 10MG/ML, ZIDOVEX 50mg/5ml (Zidovudine Oral Solution 50 mg/5ml)Buprenorphine
go.drugbank.com/drugs/DB00921ApprovedIllicitInvestigationalVet approvedCombination with naloxone is intended to reduce the abuse potential of Suboxone, as naloxone is poorly absorbed by the oral route (and has no effect when taken orally), but would reverse the opioid agonist … [A186263,A186266,A186269] Buprenorphine acts as a partial mu-opioid receptor agonist with a high affinity for the receptor, but lower intrinsic activity compared to other full mu-opioid agonists such
Products: TRANSTEC 52.5UG/H 30MG, TRANSTEC 70 UG/H 40MGOfloxacin
go.drugbank.com/drugs/DB01165ApprovedInvestigationalA synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Products: Liq 20mg/ml, Floxin Tablets 300mgTemozolomide
go.drugbank.com/drugs/DB00853ApprovedInvestigational[A229848, A229858, L32033] Temozolomide is an imidazotetrazine prodrug that is stable at acidic pH but undergoes spontaneous nonenzymatic hydrolysis at neutral or slightly basic pH; these properties allow … It is currently marketed under the trademark TEMODAR® by Merck.[L32033]
Products: TEMAZ® 20MG, TEDOLIX® 20MGAmbroxol
go.drugbank.com/drugs/DB06742ApprovedInvestigationalIt stimulates synthesis and release of surfactant by type II pneumocytes. … Surfactants acts as an anti-glue factor by reducing the adhesion of mucus to the bronchial wall, in improving its transport and in providing protection against infection and irritating agents.
Mixtures: MUCOSOLVAN®COMPOSITUM GOTAS 15MG/0.01MG/2MLProducts: AMBROXOL 30MG, GIB AMBROXOL 30MGOmeprazole
go.drugbank.com/drugs/DB00338ApprovedInvestigationalVet approvedOriginally approved by the FDA in 1989, omeprazole is a _proton-pump inhibitor_, used to treat gastric acid-related disorders. … These disorders may include gastroesophageal reflux disease (GERD), peptic ulcer disease, and other diseases characterized by the oversecretion of gastric acid.
Products: OMEP 10MG, OMEP MUT 10MG